PSInvestor d/b/a www.PSInvestor.com (“Site,” “PSInvestor,” “us,” “our” or “we”) provide this website to you under the following terms and conditions (“Terms of Use”). BY CONTINUING TO USE THE SITE, YOU ARE INDICATING YOUR AGREEMENT TO […]
Highly specific rumors connect dots of deal making strategy Potentials suitors sitting on significant cash positions. Valuation gap between market cap and traditional metrics Testimonials of drug highlight strong case for approval Short interest […]
For new investors in the fun and wild penny stock realm, I guarantee most of them do not remember the infamous tale of CMKM Diamonds. Now 13 unlucky years later, there are still many shareholders […]
GALT’s upcoming phase 3 trial patient population will be without varices and includes an interim analysis. An interim analysis creates the opportunity for GALT to submit a New Drug Application (NDA) at the 18 month mark […]
Working with JD.com on future logistics collaboration Traded over 3.3 Million shares on Tuesday CTO Bruce Montgomery boasts impressive resume MAGP closed at 0.01258 +867.69% on Tuesday on volume of 3,481,434 shares. The company traded as […]
Advanced Voice Recognition Systems, Inc. Files Infringement Complaint Against Apple, Inc. claims Apple’s Siri infringes patent ‘730 will Amazon’s ALEXA be next? how about Microsoft’s Cortana? At 3pm EST, shares were trading at $0.06 up […]
The action started with less than hour before market close on Monday, when investors found the golden info of a $98M sale of Talon First Trust, LLC. Early investors doing napkin math knew it had […]
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) — AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) is pleased to announce that it has entered into a binding letter agreement dated as of June 14, […]
PSInvestor.com